Point72 Asset Management
SMMT icon

Point72 Asset Management’s Summit Therapeutics SMMT Stock Holding History

Point72 Asset Management’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9M Buy
+784,186
New +$12.7M 0.02% 986
2019
Q1 		– Sell
-445,991
Closed -$513K – 1216
2018
Q4 		$513K Sell
445,991
-18,639
-4% -$29K ﹤0.01% 872
2018
Q3 		$1.03M Sell
464,630
-262,090
-36% -$604K ﹤0.01% 845
2018
Q2 		$1.78M Sell
726,720
-23,280
-3% -$298K 0.01% 765
2018
Q1 		$9.68M Sell
750,000
-35,600
-5% -$445K 0.04% 435
2017
Q4 		$8.7M Sell
785,600
-20,871
-3% -$233K 0.04% 475
2017
Q3 		$10.1M Buy
806,471
+5,240
+0.7% +$67.9K 0.05% 393
2017
Q2 		$9.13M Hold
801,231
– – 0.05% 407
2017
Q1 		$10.6M Sell
801,231
-124,968
-13% -$1.45M 0.06% 391
2016
Q4 		$7.93M Hold
926,199
– – 0.06% 361
2016
Q3 		$8.39M Hold
926,199
– – 0.06% 312
2016
Q2 		$7.49M Sell
926,199
-3,800
-0.4% -$30.9K 0.05% 350
2016
Q1 		$6.34M Sell
929,999
-1
-0% -$8 0.05% 387
2015
Q4 		$10.7M Buy
930,000
+10,361
+1% +$108K 0.09% 273
2015
Q3 		$9.57M Buy
919,639
+7,736
+0.8% +$92.7K 0.08% 309
2015
Q2 		$9.63M Buy
911,903
+68,603
+8% +$777K 0.07% 331
2015
Q1 		$10.4M Buy
+843,300
New +$9.55M 0.07% 322

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management's SMMT Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Summit Therapeutics (SMMT) in Q1 2026: 784,186 shares worth $14.9M. The stake represents 0.02% of the portfolio and ranks #986 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in SMMT as recently as Q4 2018.

Point72 Asset Management first reported a position in SMMT in Q1 2015 and has held it in 17 quarters since. 222 funds tracked by Wall St. Rank hold SMMT as of Q1 2026.

  • Point72 Asset Management held 784,186 shares of Summit Therapeutics worth $14.9M as of Q1 2026.
  • Summit Therapeutics was a new Point72 Asset Management position in Q1 2026.
  • Summit Therapeutics made up 0.02% of Point72 Asset Management's portfolio in Q1 2026, its #986 holding.
  • Point72 Asset Management first reported a position in Summit Therapeutics in Q1 2015 and has held it in 17 quarters since.
  • 222 funds tracked by Wall St. Rank held Summit Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.